Retour sur lavenir.net
   COLRUYT 38.940 € (-0,26 %)     UMICORE 21.460 € (-0,65 %)     IBA 16.020 € (+1,39 %)     PROXIMUS 6.395 € (-0,47 %)     ELIA GROUP 124.300 € (-0,32 %)     CMB.TECH 14.060 € (-0,14 %)     SHURGARD 25.500 € (+0,59 %)     AGEAS 73.650 € (+2,43 %)     ARGENX SE 739.400 € (-0,75 %)     FAGRON 22.750 € (-1,94 %)     D'IETEREN GROUP 180.400 € (+0,56 %)     AZELIS GROUP 11.260 € (-0,44 %)     CENERGY 21.400 € (-1,56 %)     KINEPOLIS GROUP 41.150 € (+1,60 %)     BARCO 8.010 € (+1,78 %)     KBC 125.400 € (+0,60 %)     KBC ANCORA 89.300 € (+0,79 %)     AEDIFICA 70.500 € (+0,36 %)     SYENSQO 77.100 € (+0,33 %)     AB INBEV 73.680 € (-2,02 %)     BREDERODE 103.000 € (0,00 %)     ACKERMANS V.HAAREN 270.800 € (+0,59 %)     UCB 222.900 € (0,00 %)     OPTION 4.150 € (0,00 %)     WDP 22.360 € (+0,18 %)     RETAIL ESTATES 66.400 € (+0,61 %)     BEKAERT 39.250 € (-1,51 %)     VGP 85.100 € (+0,83 %)     TUBIZE-FIN 194.200 € (+0,10 %)     SOFINA 246.200 € (+0,16 %)     SOLVAY 26.660 € (+0,38 %)     EKOPAK 3.770 € (+3,86 %)     DEME GROUP 165.600 € (+0,24 %)     CARE PROPERTY INV. 12.720 € (+0,63 %)     ATENOR 1.525 € (+1,67 %)     EVS 27.900 € (+1,27 %)     GBL 78.000 € (-0,19 %)     LOTUS BAKERIES 11 080.000 € (-0,54 %)     ECONOCOM GROUP 1.480 € (+2,78 %)     MONTEA 68.500 € (+0,74 %)     RECTICEL 12.480 € (+0,65 %)     XIOR 27.900 € (+1,09 %)     ONTEX GROUP 2.400 € (+3,67 %)     SIPEF 90.200 € (-0,55 %)     ONWARD MEDICAL 2.380 € (+2,15 %)     TINC 11.480 € (+0,88 %)     BPOST 1.556 € (+3,60 %)     VAN DE VELDE 30.200 € (0,00 %)     MELEXIS 69.100 € (+1,17 %)     GIMV 44.750 € (+0,22 %)     CIE BOIS SAUVAGE 305.000 € (0,00 %)     TITAN S.A. 52.350 € (+0,38 %)     NYXOAH 1.236 € (+1,31 %)     HYLORIS 4.700 € (-1,67 %)     WERELDHAVE BELGIUM 53.000 € (-0,38 %)     BIOTALYS 2.480 € (0,00 %)     OXURION 0.003 € (+8,33 %)     HOME INVEST BE. 20.250 € (+0,50 %)     TESSENDERLO 21.600 € (+1,17 %)     QUESTFOR GR-PRICAF 2.970 € (0,00 %)  
   LIGHTON 3.900 € (0,00 %)     CVC CAPITAL 15.120 € (+4,20 %)     AYVENS 11.810 € (+1,55 %)     OPMOBILITY 12.985 € (+1,45 %)     FDJ UNITED 22.020 € (+0,41 %)     METAVISIO 0.001 € (0,00 %)     VIRIDIEN 90.100 € (-3,01 %)     FORVIA 9.236 € (+4,03 %)     ADVICENNE 1.718 € (+4,76 %)     CAPGEMINI 106.300 € (+3,71 %)     EURONEXT 157.400 € (-0,76 %)     TELEPERFORMANCE 68.380 € (-0,90 %)     CSG 17.298 € (+4,71 %)     KERING 284.650 € (+0,16 %)     GTT 195.700 € (0,00 %)     ADYEN 895.800 € (+2,16 %)     VALEO 15.110 € (+1,55 %)     ASML HOLDING 1 427.400 € (-0,47 %)     PUBLICIS GROUPE SA 93.640 € (+1,10 %)     HERMES INTL 1 549.500 € (+1,18 %)     SANOFI 75.460 € (+1,33 %)     Vusion 128.200 € (-1,31 %)     ESSILORLUXOTTICA 164.950 € (+0,55 %)     RENAULT 28.430 € (+4,29 %)     SAINT GOBAIN 83.000 € (+2,12 %)     VALLOUREC 19.220 € (+2,45 %)     SHELL PLC 39.100 € (-1,56 %)     SONAE 2.040 € (0,00 %)     LVMH 482.000 € (+1,44 %)     ING GROEP N.V. 30.050 € (-1,28 %)     PLUXEE 14.300 € (+0,85 %)     SOITEC 106.250 € (+2,16 %)     SOCIETE GENERALE 82.650 € (+1,65 %)     INTERPARFUMS 24.760 € (+0,65 %)     POSTNL 0.964 € (+7,41 %)     STMICROELECTRONICS 45.685 € (+0,02 %)     BE SEMICONDUCTOR 199.650 € (+0,71 %)     ASM INTERNATIONAL 796.600 € (-0,57 %)     DASSAULT SYSTEMES 20.770 € (+3,59 %)     EDP 4.419 € (-1,14 %)     TOTALENERGIES 74.920 € (-1,96 %)     UMG 14.425 € (-0,07 %)     AXA 44.760 € (-0,40 %)     PROSUS 41.050 € (+2,71 %)     CARBIOS 7.540 € (+2,59 %)     HAFFNER ENERGY 0.352 € (+8,15 %)     SIF HOLDING 3.935 € (+0,13 %)     MERSEN 41.140 € (+10,47 %)     WORLDLINE 13.018 € (+6,81 %)     ACCOR 46.180 € (+2,85 %)     CRCAM NORM.SEINE 163.000 € (+0,62 %)     EDENRED 28.380 € (-0,49 %)     AIRBUS 208.400 € (+3,07 %)     THALES 249.400 € (+1,42 %)     ENGIE 26.720 € (-1,44 %)     VALNEVA 2.161 € (+0,61 %)     COFACE 15.740 € (-0,38 %)     EBUSCO HOLDING 0.260 € (-0,19 %)     PHILIPS KON 23.090 € (+1,54 %)     ELIS 25.460 € (+2,74 %)  
BUREAU VERITAS
BVI - FR0006174348 - Euronext Paris
27,870 €  09:18
+0,76 %
30/06/2026 07:30

BUREAU VERITAS - In line with the LEAP | 28 portfolio rotation strategy, Bureau Veritas signs an agreement to sell its Oil & Petrochemicals and Coal Testing and Inspection business

PRESS RELEASE

Courbevoie – June 30, 2026

In line with the LEAP | 28 portfolio rotation strategy, Bureau Veritas signs an agreement to sell its Oil & Petrochemicals and Coal Testing and Inspection business

Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), announces that it has entered exclusive negotiations with Triton Partners regarding the sale of its Oil & Petrochemicals and Coal testing and inspection business. This strategic divestment is in full alignment with the Group’s LEAP | 28 strategy.

The proposed transaction would include the Oil & Petrochemicals and Coal testing and inspection activities. In 2025, this business generated approximately EUR 450 million in revenue operating a global network across multiple countries, with a significant footprint of operational sites and employees.

This business grew at a lower rate than the Group and is margin dilutive. It is included within Bureau Veritas’ “Optimize value and impact” portfolio and reported under the Agri-Food & Commodities division. The transaction supports the strategic objective to increase exposure to higher growth and margin businesses.

A key milestone in LEAP | 28 portfolio rotation

This transaction represents a significant milestone in Bureau Veritas’ portfolio transformation. Following completion and taking into account other recent acquisitions year-to-date, the Group will have executed approximately 20% portfolio rotation since the launch of LEAP | 28.

“This divestment is fully aligned with our LEAP | 28 strategy and our commitment to actively manage our portfolio,” said Hinda Gharbi, Chief Executive Officer of Bureau Veritas. “The Oil & Petrochemicals and Coal business operates in established and mature markets, and is led by a global team. Under the leadership of Triton Partners, we are confident that this business will continue to develop successfully. This transaction will create shareholders value as Bureau Veritas accelerates its planned portfolio pivots towards higher growth and higher margin activities.

The transaction, based on an enterprise value of EUR 470 million, implies an EV/EBIT multiple of 11.1x on 2025 results post IFRS16. The disposal will have a positive impact on the Group’s organic growth profile, adjusted operating margin and return on capital employed. The deal is anticipated to be broadly neutral to earnings after closing.

Bureau Veritas intends to redeploy the proceeds towards higher-growth and higher-margin businesses, in line with LEAP I 28 portfolio ambitions.

Transaction terms and timetable

This contemplated transaction, currently under negotiation, will be subject to information and consultation procedures with the relevant employee representative bodies, and could be finalized by the end of Q1 2027, subject to the fulfillment of customary conditions precedent.

***

About Bureau Veritas:

Bureau Veritas is a world leader in inspection, certification, and laboratory testing services with a powerful purpose: to shape a world of trust by ensuring responsible progress. With a vision to be the preferred partner for customers’ excellence and sustainability, the company innovates to help them navigate change.

Created in 1828, Bureau Veritas’ 82,000 employees deliver services in 140 countries. The company’s technical experts support customers to address challenges in quality, health and safety, environmental protection, and sustainability.

Bureau Veritas is listed on Euronext Paris and belongs to the CAC 40, CAC 40 ESG, SBF 120 indices and is part of the CAC SBT 1.5° index. Compartment A, ISIN code FR 0006174348, stock symbol: BVI.

For more information, visit http://www.bureauveritas.com, and follow us on LinkedIn.

Our information is certified with blockchain technology.

Check that this press release is genuine at www.wiztrust.com.

ANALYST/INVESTOR CONTACTS

Laurent Brunelle

+33 (0) 7 79 52 69 21

laurent.brunelle@bureauveritas.com

Colin Verbrugghe

+33 (0) 6 80 53 26 72

colin.verbrugghe@bureauveritas.com

Romain Gorge

romain.gorge@bureauveritas.com

MEDIA CONTACTS

Karine Havas

+33 (0) 6 68 63 83 18

karine.havas@bureauveritas.com

Frédéric Vallois

+33 (0) 6 21 66 31 04

frederic.vallois@bureauveritas.com

Inès Lagoutte

ines.lagoutte@bureauveritas.com

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière